James F. Young, President, R&D at MEDIMMUNE INC /DE (MEDI), sold 8,640 shares at $32.62 ($282K) on 2006-02-03, disclosed to the SEC on 2006-02-07.
Open-market sale of $282k MEDI by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |